aspirin has been researched along with Ventricular Fibrillation in 29 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effect of the nitro-derivative of aspirin, NCX4016, was assessed on ischaemic ventricular arrhythmias and myocardial infarct size in anaesthetized pigs in comparison to native aspirin." | 7.71 | NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. ( Del Soldato, P; Miller, AM; Wainwright, CL; Work, LM, 2002) |
| "We describe the mortality during the subsequent 5 years after development of acute myocardial infarction prior to and after the introduction of a more widespread use of thrombolytic agents and aspirin in the community of Göteborg." | 7.70 | Long-term survival after development of acute myocardial infarction has improved after a more widespread use of thrombolysis and aspirin. ( Abrahamsson, P; Dellborg, M; Herlitz, J; Karlson, BW; Karlsson, T; Lindqvist, J, 1999) |
| "The effects of aspirin and indomethacin on the ventricular arrhythmias produced by ligation (ischaemia) and unligation (reperfusion) of the circumflex branch of the left coronary vessel were evaluated in fifty male rabbits weighing 1." | 7.69 | Effects of aspirin and indomethacin on ventricular arrhythmias--comparative study. ( Bhatti, AS; Khan, HH, 1994) |
| "The effects of arginine aspirin (AAs) on the effective refractory period (ERP) and ventricular fibrillation threshold (VFT) of ischemic ventricular muscle were observed in 24 anesthetized open-chest rabbits." | 7.67 | [Effects of arginine aspirin on changes in effective refractory period and ventricular fibrillation threshold of ischemic myocardium in rabbit]. ( Wu, BW; Zang, YM; Zhao, RR; Zhao, ZQ; Zhou, YY; Zhu, MZ, 1989) |
| "ASA, captopril or losartan were given at a concentration of 40 mg/kg/day in drinking water." | 5.32 | Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function. ( Browne, AE; Chatterjee, K; Grossman, W; Karliner, JS; Lee, RJ; Parmley, WW; Sievers, RE; Zhu, BQ, 2003) |
| "In the CLARITY-TIMI 28 (Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis In Myocardial Infarction 28) study, 3,491 patients underwent angiography a median of 3." | 5.13 | Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. ( Buros, JL; Cannon, CP; Gibson, CM; Josephson, ME; Lord, E; Murphy, SA; Pinto, DS; Pride, YB; Sabatine, MS; Shui, A; Zimetbaum, PJ, 2008) |
| " We present a case of postoperative simultaneous left anterior descending and right coronary stent thrombosis that followed cessation of long-term aspirin therapy in a patient with stable coronary artery disease." | 3.78 | Simultaneous left anterior descending and right coronary stent thrombosis after aspirin withdrawal. ( Abdelmalak, HD; Camporesi, EM; Karlnoski, R; Mangar, D; Omar, HR, 2012) |
| " The effect of the nitro-derivative of aspirin, NCX4016, was assessed on ischaemic ventricular arrhythmias and myocardial infarct size in anaesthetized pigs in comparison to native aspirin." | 3.71 | NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. ( Del Soldato, P; Miller, AM; Wainwright, CL; Work, LM, 2002) |
| "We describe the mortality during the subsequent 5 years after development of acute myocardial infarction prior to and after the introduction of a more widespread use of thrombolytic agents and aspirin in the community of Göteborg." | 3.70 | Long-term survival after development of acute myocardial infarction has improved after a more widespread use of thrombolysis and aspirin. ( Abrahamsson, P; Dellborg, M; Herlitz, J; Karlson, BW; Karlsson, T; Lindqvist, J, 1999) |
| "Mortality after acute myocardial ischemia has been reduced by aspirin (ASA) but mechanisms other than the antiplatelet effect have not been established." | 3.70 | Nonplatelet effects of aspirin during acute coronary occlusion: electrophysiologic and cation alterations in ischemic myocardium. ( Arena, J; Moschos, CB; Regan, TJ; Shehadeh, AA, 2000) |
| "The effects of aspirin and indomethacin on the ventricular arrhythmias produced by ligation (ischaemia) and unligation (reperfusion) of the circumflex branch of the left coronary vessel were evaluated in fifty male rabbits weighing 1." | 3.69 | Effects of aspirin and indomethacin on ventricular arrhythmias--comparative study. ( Bhatti, AS; Khan, HH, 1994) |
| "To evaluate the impact of introducing thrombolytic and aspirin therapy into the management policy of a coronary care unit, with particular reference to its effects on the hospital course of nonselected patients with acute myocardial infarction." | 3.68 | Clinical impact of introducing thrombolytic and aspirin therapy into the management policy of a coronary care unit. ( Ranjadayalan, K; Timmis, AD; Umachandran, V, 1992) |
| "The effects of arginine aspirin (AAs) on the effective refractory period (ERP) and ventricular fibrillation threshold (VFT) of ischemic ventricular muscle were observed in 24 anesthetized open-chest rabbits." | 3.67 | [Effects of arginine aspirin on changes in effective refractory period and ventricular fibrillation threshold of ischemic myocardium in rabbit]. ( Wu, BW; Zang, YM; Zhao, RR; Zhao, ZQ; Zhou, YY; Zhu, MZ, 1989) |
| " There was no lysozymuria with severe uraemic heart failure, aspirin and paracetamol poisoning, or severe jaundice, nor in two cases of acute glomerulonephritis." | 3.65 | Lysozymuria and acute disorders of renal function. ( De Silva, KL; Harrison, JF; Parker, RW, 1973) |
| "We analyzed the incidence and recurrence rate of early and late primary VF in 9,720 patients with a first acute MI, treated with thrombolytics, enrolled in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 trial." | 2.69 | Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database. ( Cavalli, A; Negri, E; Santoro, L; Volpi, A, 1998) |
| "ASA, captopril or losartan were given at a concentration of 40 mg/kg/day in drinking water." | 1.32 | Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function. ( Browne, AE; Chatterjee, K; Grossman, W; Karliner, JS; Lee, RJ; Parmley, WW; Sievers, RE; Zhu, BQ, 2003) |
| " After controlling for age, prehospital dosage of epinephrine, and the duration of cardiac arrest we found a non significant trend towards good neurological recovery when thrombolytic therapy was given (OR 1." | 1.31 | Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. ( Gabriel, D; Holzer, M; Kuerkciyan, I; Laggner, AN; Muellner, M; Schreiber, W; Sterz, F, 2002) |
| "An increase in the risk of ventricular arrhythmias under conditions of both ischaemia and reperfusion was obvious in the rats that consumed large quantities of saturated fatty acids (coconut oil) and in the group with a very low intake of fat." | 1.29 | Differential effects of various oil diets on the risk of cardiac arrhythmias in rats. ( Isensee, H; Jacob, R, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (27.59) | 18.7374 |
| 1990's | 8 (27.59) | 18.2507 |
| 2000's | 9 (31.03) | 29.6817 |
| 2010's | 2 (6.90) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Eroglu, TE | 1 |
| Blom, MT | 1 |
| Souverein, PC | 1 |
| Yasmina, A | 1 |
| de Boer, A | 1 |
| Tan, HL | 1 |
| Mercado-Lubo, R | 1 |
| Yarzebski, J | 1 |
| Lessard, D | 1 |
| Gore, J | 1 |
| Goldberg, RJ | 1 |
| Jang, SW | 1 |
| Kim, DB | 1 |
| Kwon, BJ | 1 |
| Shin, D | 1 |
| Her, SH | 1 |
| Park, CS | 1 |
| Park, HJ | 1 |
| Park, MW | 1 |
| Cho, EJ | 1 |
| Rho, TH | 1 |
| Kim, JH | 1 |
| Omar, HR | 1 |
| Mangar, D | 1 |
| Karlnoski, R | 1 |
| Abdelmalak, HD | 1 |
| Camporesi, EM | 1 |
| Seniuk, W | 1 |
| Mularek-Kubzdela, T | 1 |
| Grygier, M | 1 |
| Grajek, S | 1 |
| Cieśliński, A | 1 |
| Al-Khatib, SM | 1 |
| Stebbins, AL | 1 |
| Califf, RM | 1 |
| Lee, KL | 1 |
| Granger, CB | 1 |
| White, HD | 1 |
| Armstrong, PW | 1 |
| Topol, EJ | 1 |
| Ohman, EM | 1 |
| Zhu, BQ | 1 |
| Sievers, RE | 1 |
| Browne, AE | 1 |
| Lee, RJ | 1 |
| Chatterjee, K | 1 |
| Grossman, W | 1 |
| Karliner, JS | 1 |
| Parmley, WW | 1 |
| Gibson, CM | 1 |
| Pride, YB | 1 |
| Buros, JL | 1 |
| Lord, E | 1 |
| Shui, A | 1 |
| Murphy, SA | 1 |
| Pinto, DS | 1 |
| Zimetbaum, PJ | 1 |
| Sabatine, MS | 1 |
| Cannon, CP | 1 |
| Josephson, ME | 1 |
| Boissel, JP | 1 |
| Leizorovicz, A | 1 |
| Faucomprez, C | 1 |
| Packham, MA | 1 |
| Mustard, JF | 1 |
| Bhatti, AS | 1 |
| Khan, HH | 1 |
| Isensee, H | 1 |
| Jacob, R | 1 |
| Barrabés, JA | 1 |
| Garcia-Dorado, D | 1 |
| Oliveras, J | 1 |
| González, MA | 1 |
| Ruiz-Meana, M | 1 |
| Solares, J | 1 |
| Burillo, AG | 1 |
| Lidón, RM | 1 |
| Antolín, M | 1 |
| Castell, J | 1 |
| Soler-Soler, J | 1 |
| Dhein, S | 1 |
| Gottwald, M | 1 |
| Gottwald, E | 1 |
| Hohlfeld, T | 1 |
| Salameh, A | 1 |
| Klaus, W | 1 |
| Volpi, A | 1 |
| Cavalli, A | 1 |
| Santoro, L | 1 |
| Negri, E | 1 |
| Herlitz, J | 1 |
| Abrahamsson, P | 1 |
| Dellborg, M | 1 |
| Karlson, BW | 1 |
| Karlsson, T | 1 |
| Lindqvist, J | 1 |
| Jeong, MH | 1 |
| Park, JC | 2 |
| Rhew, JY | 1 |
| Kang, KT | 1 |
| Lee, SH | 1 |
| Cho, JH | 1 |
| Kim, NH | 1 |
| Kim, KH | 1 |
| Ahn, YK | 1 |
| Bae, Y | 1 |
| Cho, JG | 1 |
| Kim, SH | 1 |
| Kang, JC | 1 |
| Shehadeh, AA | 1 |
| Arena, J | 1 |
| Moschos, CB | 2 |
| Regan, TJ | 2 |
| Gheeraert, PJ | 1 |
| Henriques, JP | 1 |
| De Buyzere, ML | 1 |
| De Pauw, M | 1 |
| Taeymans, Y | 1 |
| Zijlstra, F | 1 |
| Schreiber, W | 1 |
| Gabriel, D | 1 |
| Sterz, F | 1 |
| Muellner, M | 1 |
| Kuerkciyan, I | 1 |
| Holzer, M | 1 |
| Laggner, AN | 1 |
| Wainwright, CL | 1 |
| Miller, AM | 1 |
| Work, LM | 1 |
| Del Soldato, P | 1 |
| Wilkerson, RD | 1 |
| Glenn, TM | 1 |
| Haider, B | 1 |
| De La Cruz, C | 1 |
| Lyons, MM | 1 |
| Gustafson, A | 1 |
| Gustafsson, B | 1 |
| Ranjadayalan, K | 1 |
| Umachandran, V | 1 |
| Timmis, AD | 1 |
| Oates, JA | 1 |
| Zhao, ZQ | 1 |
| Zang, YM | 1 |
| Zhu, MZ | 1 |
| Zhou, YY | 1 |
| Wu, BW | 1 |
| Zhao, RR | 1 |
| Huang, TF | 1 |
| Yang, BB | 1 |
| Harrison, JF | 1 |
| Parker, RW | 1 |
| De Silva, KL | 1 |
3 reviews available for aspirin and Ventricular Fibrillation
| Article | Year |
|---|---|
Cardiac death prevention in post-myocardial infarction patients: a review.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Animals; Anti-Arrhythmia Agents; Anticoagu | 1980 |
Pharmacology of platelet-affecting drugs.
Topics: Animals; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Cyclic AMP; Dose-Response Re | 1980 |
The Jeremiah Metzger lecture. Participation of eicosanoids in the syndromes of myocardial ischemia.
Topics: Angina, Unstable; Arteriosclerosis; Aspirin; Coronary Disease; Eicosanoids; Humans; Myocardial Infar | 1990 |
4 trials available for aspirin and Ventricular Fibrillation
| Article | Year |
|---|---|
Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.
Topics: Acute Disease; Aged; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Heparin; Hospi | 2003 |
Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Circulati | 2008 |
Cardiac death prevention in post-myocardial infarction patients: a review.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Animals; Anti-Arrhythmia Agents; Anticoagu | 1980 |
Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atenolol; Drug Administration Routes; Electrocardio | 1998 |
23 other studies available for aspirin and Ventricular Fibrillation
| Article | Year |
|---|---|
Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study.
Topics: Aspirin; Calcium; Cardiopulmonary Resuscitation; Case-Control Studies; Female; Humans; Male; Myocard | 2022 |
Changing Trends in the Landscape of Patients Hospitalized With Acute Myocardial Infarction (2001 to 2011) (from the Worcester Heart Attack Study).
Topics: Adrenergic beta-Antagonists; Age Distribution; Aged; Aged, 80 and over; Angiotensin Receptor Antagon | 2020 |
Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occ | 2010 |
Simultaneous left anterior descending and right coronary stent thrombosis after aspirin withdrawal.
Topics: Aged; Aspirin; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stent | 2012 |
Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study.
Topics: Amiodarone; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Car | 2002 |
Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhib | 2003 |
Effects of aspirin and indomethacin on ventricular arrhythmias--comparative study.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Blood Pressure; Cardiac Complexes, Premature; Cause of Death | 1994 |
Differential effects of various oil diets on the risk of cardiac arrhythmias in rats.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Cardiac Complexes, Premature; Coconut Oil; Cocos; Corn Oil; | 1994 |
Intimal injury in a transiently occluded coronary artery increases myocardial necrosis. Effect of aspirin.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bleeding Time; Blood Cell Count; Coronary | 1996 |
Acetylsalicylic acid enhances arrhythmogeneity in a model of local ischemia of isolated rabbit hearts.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arrhythmias, Cardiac; Aspirin; Coronary Circulatio | 1997 |
Long-term survival after development of acute myocardial infarction has improved after a more widespread use of thrombolysis and aspirin.
Topics: Aged; Aspirin; Cardiotonic Agents; Confidence Intervals; Female; Fibrinolytic Agents; Humans; Likeli | 1999 |
Successful management of intractable coronary spasm with a coronary stent.
Topics: Adult; Amlodipine; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angiography; C | 2000 |
Nonplatelet effects of aspirin during acute coronary occlusion: electrophysiologic and cation alterations in ischemic myocardium.
Topics: Action Potentials; Animals; Aspirin; Coronary Disease; Dogs; Epinephrine; Male; Myocardial Ischemia; | 2000 |
Preinfarction angina protects against out-of-hospital ventricular fibrillation in patients with acute occlusion of the left coronary artery.
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Angina Pectoris; Aspirin; Case-Control Stud | 2001 |
Thrombolytic therapy after cardiac arrest and its effect on neurological outcome.
Topics: Aged; Aspirin; Cardiopulmonary Resuscitation; Case-Control Studies; Cerebrovascular Circulation; Con | 2002 |
NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arrhythmias, Cardiac; Aspirin; Coronary Disease; E | 2002 |
Influence of nonsteroidal anti-inflammatory drugs on ouabain toxicity.
Topics: Animals; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Aspirin; Cyclooxygenase Inhibitors; Dogs; F | 1977 |
Antiarrhythmic effects of aspirin during nonthrombotic coronary occlusion.
Topics: Animals; Anti-Arrhythmia Agents; Aspirin; Blood Pressure; Coronary Disease; Dogs; Fatty Acids, Nones | 1978 |
Acute poisoning with dextropropoxyphene. Clinical symptoms and plasma concentrations.
Topics: Acidosis; Acute Disease; Adolescent; Adult; Arrhythmia, Sinus; Aspirin; Barbiturates; Dextropropoxyp | 1976 |
Clinical impact of introducing thrombolytic and aspirin therapy into the management policy of a coronary care unit.
Topics: Age Factors; Aged; Aspirin; Coronary Care Units; Diuretics; Drug Therapy, Combination; Female; Hospi | 1992 |
[Effects of arginine aspirin on changes in effective refractory period and ventricular fibrillation threshold of ischemic myocardium in rabbit].
Topics: Animals; Aspirin; Coronary Disease; Female; Male; Neural Conduction; Platelet Aggregation; Platelet | 1989 |
Effects of vagotomy and drugs on the ventricular fibrillation threshold of normal and ischemic hearts in the anesthetized rat.
Topics: Adenosine; Anesthesia; Animals; Aspirin; Blood Pressure; Bretylium Compounds; Coronary Disease; Hear | 1985 |
Lysozymuria and acute disorders of renal function.
Topics: Acetaminophen; Acute Disease; Aspirin; Electroshock; Glomerulonephritis; Heart Failure; Humans; Hypo | 1973 |